How common thrombocytopenia is depends entirely on who you’re looking at. In the general population, it’s relatively uncommon. But in certain groups, like pregnant women, hospitalized patients, or people with liver disease, low platelet counts are strikingly frequent. A platelet count below 150,000 per microliter of blood is the standard cutoff, and the condition ranges from mild cases that cause no symptoms to severe drops that trigger spontaneous bleeding.
Prevalence in the General Population
Among otherwise healthy adults, thrombocytopenia is not especially common. The most well-studied form, immune thrombocytopenia (ITP), affects roughly 9.5 people per 100,000 in the general population. Women are nearly twice as likely to develop it as men: about 11.3 per 100,000 women compared to 6.1 per 100,000 men. New cases of ITP appear at a rate of about 1.4 to 2.6 per 100,000 people each year, depending on the country studied.
Age matters too. In one large analysis of privately insured Americans, prevalence was lowest in teens and young adults (around 4 to 6 per 100,000) and highest in people aged 55 to 64 (16 per 100,000). Children between ages 1 and 5 had a prevalence of about 9.3 per 100,000, while chronic ITP specifically affected roughly 4.6 per 100,000 children.
Pregnancy: Surprisingly Frequent
Thrombocytopenia is far more common during pregnancy than most people realize. Between 7% and 11% of all pregnancies involve some degree of low platelet counts. That makes it one of the most common blood abnormalities in pregnant women.
About 75% of these cases are gestational thrombocytopenia, a benign condition that develops in later pregnancy, causes only mildly low platelet counts, and resolves on its own after delivery. Pre-eclampsia accounts for roughly 20% of pregnancy-related cases, while ITP causes 1% to 4%. Rarer conditions like blood clotting disorders and disseminated intravascular coagulation each account for less than 1%.
Hospitalized and ICU Patients
In hospitals, thrombocytopenia is remarkably common. Among critically ill patients in intensive care, nearly 60% develop low platelet counts during their stay. The highest rates occur in emergency surgery patients (77%) and trauma patients (72%). Severe thrombocytopenia, where platelets drop below 20,000 per microliter, affects about 10% to 18% of emergency surgical and medical ICU patients.
Infections drive much of this. Among ICU patients with bloodstream infections, nearly 19% develop severe thrombocytopenia. The platelet drop in hospitalized patients often reflects the body’s response to sepsis, major blood loss, or the effects of multiple medications rather than a primary blood disorder.
Liver Disease and Cirrhosis
Up to 76% of people with chronic liver disease have some degree of thrombocytopenia, making it one of the most common complications in this group. The rate climbs even higher in patients with cirrhosis. The liver produces a hormone called thrombopoietin that signals the bone marrow to make platelets, so when the liver is damaged, platelet production drops. At the same time, an enlarged spleen (common in cirrhosis) traps and destroys platelets faster than usual.
Cancer Treatment
Chemotherapy is one of the most common triggers for low platelet counts. Within three months of starting chemotherapy, about 15% of all cancer patients develop thrombocytopenia. The risk varies by cancer type: 13% of patients with solid tumors (like breast, lung, or colon cancer) are affected, compared to 28% of patients with blood cancers like lymphoma or leukemia.
Severe drops are more common in blood cancers. About 12% of those patients see their platelets fall below 25,000 per microliter, a level that carries real bleeding risk, compared to just 2% of patients with solid tumors. These drops often require chemotherapy dose reductions or delays, which can affect treatment outcomes.
Rarer Forms
Some types of thrombocytopenia are genuinely rare. Thrombotic thrombocytopenic purpura (TTP), a serious condition where tiny blood clots form throughout the body and consume platelets, affects roughly 2 to 6 people per million each year. The inherited form is even rarer, at about 0.3 cases per million. Both forms meet the medical definition of ultra-rare diseases.
Drug-induced thrombocytopenia is more common than TTP but still relatively unusual. Over 300 medications have been linked to low platelet counts. The blood thinner heparin is the most frequent culprit. Other commonly implicated drugs include certain antibiotics, anti-seizure medications, anti-inflammatory painkillers, and chemotherapy agents. Among reported cases, about 9% involve major bleeding and 0.8% are fatal.
When Platelet Counts Become Dangerous
Not all thrombocytopenia carries the same risk. The condition is classified as moderate when platelets fall between 50,000 and 100,000 per microliter, and severe below 50,000. Many people with mild thrombocytopenia (100,000 to 150,000) have no symptoms at all and discover it incidentally through routine blood work.
The real danger zone starts below 20,000, where spontaneous bleeding can occur without any injury. This might show up as nosebleeds, bleeding gums, blood in urine or stool, or small red or purple dots on the skin called petechiae. Below 5,000, the risk of severe, life-threatening spontaneous bleeding rises sharply. Most people with platelet counts above 50,000 can go about their daily lives without significant bleeding risk, though they may bruise more easily and bleed longer from cuts.